| 000 | 01270 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514220506.0 | ||
| 264 | 0 | _c20051018 | |
| 008 | 200510s 0 0 eng d | ||
| 022 | _a1381-6128 | ||
| 024 | 7 |
_a10.2174/1381612053382142 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFurness, M S | |
| 245 | 0 | 0 |
_aAntiangiogenic agents: studies on fumagillin and curcumin analogs. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2005 |
||
| 300 |
_a357-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCurcumin _xanalogs & derivatives |
| 650 | 0 | 4 | _aCyclohexanes |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 |
_aFatty Acids, Unsaturated _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aSesquiterpenes |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 700 | 1 | _aRobinson, T P | |
| 700 | 1 | _aEhlers, T | |
| 700 | 1 | _aHubbard, R B | |
| 700 | 1 | _aArbiser, J L | |
| 700 | 1 | _aGoldsmith, D J | |
| 700 | 1 | _aBowen, J P | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 11 _gno. 3 _gp. 357-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1381612053382142 _zAvailable from publisher's website |
| 999 |
_c15398625 _d15398625 |
||